CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells - PubMed (original) (raw)

. 1997 Sep;15(11):1315-27.

doi: 10.1038/sj.onc.1201305.

Affiliations

• PMID: 9315100
• DOI: 10.1038/sj.onc.1201305

CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells

W Cao et al. Oncogene. 1997 Sep.

Abstract

CBF beta-SMMHC is expressed from the inv(16) chromosome in M4Eo AML. Mice lacking CBF subunits or expressing the CBF beta-SMMHC or AML1-ETO oncoproteins failed to develop definitive hematopoiesis. To investigate these effects on hematopoiesis, we expressed CBF beta-SMMHC from the metallothionein promoter, in both 32D cl3 myeloid cells and Ba/F3 B-lymphoid cells. Addition of zinc increased CBF beta-SMMHC levels more than tenfold, with higher levels evident in Ba/F3 lines. Levels obtained in 32D cl3 cells were similar to those of endogenous CBF beta. Indirect immunofluorescence revealed zinc-inducible speckled, nuclear staining in Ba/F3 cells and diffuse nuclear staining in 32D cl3 cells. CBF beta-SMMHC reduced endogenous CBF DNA-binding fivefold in both cell types, increased cell generation time 1.9-fold, on average, in 32D cl3 cells and 1.5-fold in Ba/ F3 cells and decreased tritiated thymidine incorporation into DNA correspondingly. CBF beta-SMMHC increased the proportion of cells in G1 1.7-fold, on average, in 32D cl3 and Ba/F3 cells, and decreased the proportion of cells in S phase by a similar degree. CBF beta-SMMHC induced a marked increase in hypophosphorylated Rb, but did not alter IL-3 Receptor alpha or beta subunit levels. Neither apoptosis nor 32D differentiation was induced by zinc in IL-3 in these lines. Induction of CBF beta-SMMHC in 32D cl3 cells did not inhibit their differentiation to neutrophils or their expression of myeloperoxidase mRNA in G-CSF, and did not produce an eosinophilic phenotype. Additional, proliferative genetic changes in M4eo AMLs might potentiate inhibition of differentiation by CBF beta-SMMHC by allowing its increased expression.

PubMed Disclaimer

Similar articles

• AML1 stimulates G1 to S progression via its transactivation domain.
  Bernardin F, Friedman AD. Bernardin F, et al. Oncogene. 2002 May 9;21(20):3247-52. doi: 10.1038/sj.onc.1205447. Oncogene. 2002. PMID: 12082641
• Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.
  Shigesada K, van de Sluis B, Liu PP. Shigesada K, et al. Oncogene. 2004 May 24;23(24):4297-307. doi: 10.1038/sj.onc.1207748. Oncogene. 2004. PMID: 15156186 Review.
• Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.
  Liu PP, Hajra A, Wijmenga C, Collins FS. Liu PP, et al. Blood. 1995 May 1;85(9):2289-302. Blood. 1995. PMID: 7727763 Review. No abstract available.

Cited by

• Runx1 loss minimally impacts long-term hematopoietic stem cells.
  Cai X, Gaudet JJ, Mangan JK, Chen MJ, De Obaldia ME, Oo Z, Ernst P, Speck NA. Cai X, et al. PLoS One. 2011;6(12):e28430. doi: 10.1371/journal.pone.0028430. Epub 2011 Dec 1. PLoS One. 2011. PMID: 22145044 Free PMC article.
• Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation.
  Zhang L, Fried FB, Guo H, Friedman AD. Zhang L, et al. Blood. 2008 Feb 1;111(3):1193-200. doi: 10.1182/blood-2007-08-109702. Epub 2007 Nov 14. Blood. 2008. PMID: 18003885 Free PMC article.
• Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.
  Alder JK, Georgantas RW 3rd, Hildreth RL, Kaplan IM, Morisot S, Yu X, McDevitt M, Civin CI. Alder JK, et al. J Immunol. 2008 Apr 15;180(8):5645-52. doi: 10.4049/jimmunol.180.8.5645. J Immunol. 2008. PMID: 18390749 Free PMC article.
• Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.
  Leong WY, Guo H, Ma O, Huang H, Cantor AB, Friedman AD. Leong WY, et al. J Biol Chem. 2016 Jan 8;291(2):826-36. doi: 10.1074/jbc.M115.674234. Epub 2015 Nov 23. J Biol Chem. 2016. PMID: 26598521 Free PMC article.
• Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
  Day RB, Hickman JA, Xu Z, Katerndahl CD, Ferraro F, Ramakrishnan SM, Erdmann-Gilmore P, Sprung RW, Mi Y, Townsend RR, Miller CA, Ley TJ. Day RB, et al. J Clin Invest. 2023 Dec 7;134(4):e176311. doi: 10.1172/JCI176311. J Clin Invest. 2023. PMID: 38061017 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal